Notice of Application to Vary the Conditions of a Registered Trade Name Product (Notice No. MPI 1355)
Maree Zinzley, Manager Approvals, of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”) that the following variation application has been made to a registered trade name product under section 9(2) of the Act:
Trade Name: Conoptal Viscous Eye Drops
Reference: A05701-16
Active Ingredient and Concentration:
Fusidic Acid 10mg/g
Formulation Type: Aqueous Suspension
Current Claim:
For eye infections due to fusidic acid sensitive Staphylococci in dogs and cats.
Proposed New Claim (changes in bold):
For eye infections due to fusidic acid sensitive Staphylococci in dogs, cats and rabbits.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Charles Fergusson Building, 34–38 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Dechra Veterinary Products NZ Limited, 198A Kapiti Road, Paraparaumu 5032. Postal Address: PO Box 1604, Paraparaumu Beach 5252.
Dated at Wellington this 30th day of June 2021.
MAREE ZINZLEY, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).